The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Surveillance of drug resistant tuberculosis in Hubei, China
Author(s): 
Pages: 723-726
Year: Issue:  12
Journal: CHINESE JOURNAL OF TUBERCULOSIS AND RESPIRATORY DISEASES

Keyword:  结核药物耐受性监测;
Abstract: 目的建立以世界卫生组织(WHO)和国际防痨和肺病联合会(IUATLD)指南为基础的结核病耐药监测系统,掌握湖北省初始和获得性耐药水平,评价现行结核病控制策略效果.方法采用整群抽样方法,在全省随机抽取30个县(市、区)为监测点;各监测点连续选30个新发涂阳肺结核病例,期间的其他涂阳病例同时纳入,并对全部培养阳性菌株进行菌型鉴定及SM、INH、RFP、EMB 4种抗结核药物的药敏试验(比例法).结果共入选1 136例,其中培养阳性1 097例,培养阳性率为96.6%,污染率为0.4%.总耐药率为23.3%,其中初始耐药率为17.5%,获得性耐药率为44.5%.初始耐多药率(含H+R)为2.1%.获得性耐多药率为21.8%.结论初步建立了抗结核药物耐药性监测实验室方法和质量控制机制,首次获得可信的全省耐药水平资料.提示推行合理化疗和贯彻全程督导治疗原则对减少耐药的至关重要性和定期连续观测及深入研究的必要性.
Related Articles
loading...